The Anti-Mullerian Hormone (AMH), Female test contains 1 test with 1 biomarker.
Description: The AMH test is a blood test that checks for Anti Mullerian Hormone in your blood’s serum.
Also Known As: AMH Test, AMH Hormone Test, Mullerian-inhibiting hormone Test, MIH Test, Mullerian Inhibiting Factor Test, MIF Test, Mullerian Inhibiting Substance Test, MUS Test
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: No preparation required
Average Processing Time: 3 to 4 days
When is an Anti-Mullerian Hormone test ordered?
When a woman's ovarian function, reproductive concerns, especially when considering assisted reproduction techniques like in vitro fertilization, or when a health practitioner wishes to evaluate her chances of entering menopause, an AMH test may be recommended.
When a woman shows indications and symptoms of polycystic ovarian syndrome, AMH may be ordered.
AMH may be ordered on a regular basis for a woman with AMH-producing ovarian cancer to check therapy effectiveness and recurrence.
When an infant's genitalia is ambiguous or when a male child's testicles have not descended properly, an AMH test may be ordered.
What does an Anti-Mullerian Hormone blood test check for?
Anti-Müllerian hormone is a hormone generated by male and female reproductive tissues, including the testicles and ovaries. The role of AMH, as well as the amount generally present, varies by gender and age. This test detects the presence of AMH in the blood.
AMH is produced by the testicles early in the development of a baby boy, limiting the development of female reproductive organs while boosting the development of other male reproductive organs. AMH levels in boys stay high until adolescence, when they begin to decline.
AMH levels are low in girls, allowing for the development of female reproductive structures. Young females' AMH levels remain low until adolescence, when the ovaries begin to manufacture it and levels rise. AMH will then gradually decrease in women during their reproductive years, eventually becoming undetectable after menopause.
AMH is essential for a woman during her reproductive years. A female contains roughly one million eggs at birth, which normally decline to about 500,000 during infancy. Only a small percentage of these leftover eggs will mature into follicles, one at a time throughout a woman's monthly menstrual cycle. During the process of egg maturation and release, AMH exerts a balancing influence on the monthly cyclical actions of follicle-stimulating hormone and luteinizing hormone. This follicular expansion is reflected in the amount of AMH present.
The AMH level has been demonstrated in studies to be effective in assessing a woman's remaining egg maturation potential and her chances of conceiving. During the childbearing years, AMH decreases gradually, reduces considerably as menopause approaches, and is essentially undetectable after menopause. The level of AMH can be used to assess a woman's current reproductive status and anticipate the beginning of menopause.
Polycystic ovarian syndrome, a disorder affecting the ovaries, has been linked to elevated AMH levels. This syndrome causes unusually excessive levels of AMH to be produced by the extra follicles.
In the fetus, AMH is also important for sexual distinction. A developing fetus might develop either male or female reproductive organs throughout the first several weeks of pregnancy. The two testicles present in a baby boy produce AMH and androgens, which limit the development of female reproductive organs while promoting the growth of other male reproductive organs. Both male and basic female organs may develop if a significant amount of AMH is not accessible or lacking during this process. A baby with ambiguous genitalia may not be recognized as male or female right away.
Some ovarian cancers have high levels of AMH. If the hormone is produced by a tumor, the AMH test can be used as a tumor marker to track therapy effectiveness and check for recurrence.
Lab tests often ordered with an Anti-Mullerian Hormone test:
- FSH
- LH
- Estrogen
- Estradiol
- Testosterone Free and Total
- Progesterone
- Sex Hormone Binding Globulin
Conditions where an Anti-Mullerian Hormone test is recommended:
- PCOS
- Infertility
- Menopause
How does my health care provider use an Anti-Mullerian test?
Anti-Müllerian hormone is not a commonly requested test, but it can be helpful in some situations.
AMH is a hormone made by the reproductive organs. Its function and the amount that is generally present varies by gender and age.
An AMH test, along with other hormone tests like estradiol and FSH, may be ordered for women of reproductive age to determine how much time they have left to conceive. These tests can also be used to assess ovarian function and possibly forecast when menopause will occur.
AMH may be ordered for a woman who will be having assisted reproduction techniques such as in vitro fertilization; the amount of AMH present is linked to her potential treatment response. A low amount of AMH indicates a poor ovarian response, implying that fewer eggs will be recovered following ovarian stimulation. It's usually ordered in conjunction with additional hormone lab tests and a transvaginal ultrasound scan for this purpose.
Polycystic ovarian syndrome can be diagnosed with an AMH test. Because there are more follicles present, AMH may be raised.
AMH levels are elevated in several ovarian malignancies. If the hormone is initially increased, the test can be used as a tumor marker to assess therapy response and track recurrence.
An AMH test, together with chromosome testing, hormone testing, and sometimes imaging scans, may be requested to help establish the sex of an infant with external genitals that are not distinctly male or female.
What do my Anti Mullerian Hormone test results mean?
A low quantity and quality of eggs with diminishing fertility during a woman's reproductive years may suggest a poor number and quality of eggs, resulting in minimal or less responsiveness to IVF treatment. It could also mean that the ovaries aren't working properly.
A decrease in AMH level and/or a severe fall in AMH could indicate the start of menopause. AMH levels that are negative to low in a female are normal during childhood and after menopause.
Although an elevated level of AMH is frequently associated with PCOS, it is not diagnostic of the illness. Increased AMH may potentially signal a greater or even excessive reactivity to IVF, necessitating a modification of the treatment.
When AMH is used to track the progress of an AMH-producing ovarian cancer, a decrease in AMH suggests a positive response to treatment, whereas an increase could indicate cancer recurrence.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.
